Steatorrhea

Steatorrhea: Overview

Steatorrhea is not a really a condition but a symptom in which fecal matter is frothy, foul-smelling and floats because of a high fat content.  It is common in malabsorption syndromes. Steatorrhea is excessive excretion of fecal fat.

Causes and Development

Both digestive and absorptive disorders can cause steatorrhea.  Digestive disorders affect the production and release of the enzyme lipase from the pancreas, or bile from the liver, which are substances that aid digestion of fats; absorptive disorders disturb the absorptive and enzyme functions of the intestine.  Any condition that causes malabsorption or maldigestion is also associated with increased fecal fat.  As an example, children with cystic fibrosis have mucus plugs that block the pancreatic ducts.  The absence or significant decrease of the pancreatic enzymes, amylase, lipase, trypsin, and chymotrypsin limits fat, protein and carbohydrate digestion, resulting in steatorrhea due to fat malabsorption.

The underlying condition causes of steatorrhea include:Increased fecal fat levels are found in cystic fibrosis, malabsorption secondary to other conditions like Whipple's disease or Crohn's disease, maldigestion secondary to pancreatic or bile duct obstruction, and "short-gut" syndrome secondary to surgical resection, bypass, or congenital anomaly.

Signs and Symptoms

Steatorrhea is suspected when the patient has large, "greasy", and foul-smelling stools.  Signs of steatorrhea include:
  • Foul-smelling feces
  • Bulky stool
  • Pale stools
  • Loose stools
  • Greasy stools

Diagnosis and Tests

Pancreatic and small intestinal diseases are the major causes of steatorrhea.  If steatorrhea is due to chronic pancreatitis the bentiromide test is usually abnormal.  In order to confirm the presence of pancreatic disease, a structural abnormality in the pancreas is sought by abdominal X-ray (calcification), ultrasound, CT scan, or ERCP.

When small intestinal disease is suspected as the source of steatorrhea, function tests of intestinal absorption may be performed.  D-xylose absorption will test proximal small bowel function.  The Schilling tests (I and II) and bile acid breath tests assess distal small bowel function.  The Schilling test with antibiotics (part III) and the bile acid breath test will facilitate a diagnosis of bacterial overgrowth.  Structural abnormalities of the small bowel are detected by barium studies and/or biopsy.  Less common causes of steatorrhea require further diagnostic testing (e.g.duodenal aspiration for Giardia, serum gastrin for Zollinger-Ellison disease, etc.).

Treatment and Prevention

The dietary therapy of steatorrhea requires knowledge of the cause of the disease associated with the steatorrhea.  Once the cause is established, then an approach to the dietary management can be adopted.  Recommendations for either the treatment of the primary disease, limitation of fat intake, nutritional support, or pancreatic-enzyme replacement are made depending on the disease process.

In cases of chronic pancreatitis, a marked reduction in the secretion of pancreatic enzymes leads to steatorrhea.  The first requirement in the treatment of steatorrhea is the ingestion of potent enzymes.  A total of 30,000 units of lipase should be consumed with each meal.  A few mouthfuls of the meal should be consumed priorto ingesting any enzymes in orderto protect enzymes against the harmful effects of gastric acid.

Therapy with potent pancreatic enzymes usually reduces the passage of bulky stools and permits significant weight gain.  If this therapy is ineffective, however, the next important step in treatment of steatorrhea is the protection of enzymes against gastric acid.  This protection can be achieved by either reducing the secretion of hydrogen ions with an H2 blocker (while continuing therapy with the same potent enzymes) or by ingesting pH-sensitive enteric-coated pancreatic enzymes.  These enteric-coated preparations do not release enzymes until the milieu becomes alkaline (presumably within the duodenum).

The pH-sensitive enteric-coated enzymes may fail either because the pH within the stomach becomes alkaline prematurely (thereby permitting the premature release of enzymes which may then be exposed to a subsequent acid milieu) or because the size of the microspheres that contain the enzymes may be too large to be emptied in timely fashion from the stomach.

If pancreatic enzyme therapy with either an H2 blocker or enteric-coated preparation does not provide improvement, the next step is to decrease dietary fat to 50gm per day and to substitute medium-chain triglycerides (which do not require hydrolysis prior to absorption) for some dietary fat.

If steatorrhea persists, there may be excessive gastric secretion that requires a more potent H2 blocker.  There appear to be factors other than acid that may prevent effectiveness of pancreatic enzymes.  For example, even when sufficient pancreatic enzymes are instilled directly into the duodenum, steatorrhea may not be fully eliminated.

Steatorrhea

Information On This Page

Signs, symptoms & indicators of Steatorrhea:

Symptoms - Bowel Movements

Undigested fat in stools is a sign or symptom of SteatorrheaUndigested fat in stools
Stool fats (or fecal fats, or fecal lipids) are fats that are excreted in the feces.  When secretions from the pancreas and liver are adequate, emulsified dietary fats are almost completely absorbed in the small intestine.  When a malabsorption disorder or another cause disrupts this process, excretion of fat in the stool increases.

Risk factors for Steatorrhea:

Metabolic

Cystic Fibrosis increases risk of SteatorrheaCystic Fibrosis
Most people with cystic fibrosis have difficulty absorbing dietary fat, which in turn leads to steatorrhea.  Cystic fibrosis interferes with the ability of the pancreas to secrete digestive enzymes: fat is normally broken down by lipase, a digestive enzyme that is produced and secreted by the pancreas.

Recommendations for Steatorrhea:

Lab Tests/Rule-Outs

Stool Exam is highly recommended for SteatorrheaStool Exam
Both qualitative and quantitative tests are used to identify excessive fecal fat.  The qualitative test involves staining a specimen of stool with a special dye, then examining it microscopically for evidence of malabsorption, such as undigested muscle fiber and various fats.  The quantitative test involves drying and weighing a 72-hour stool specimen, then using an extraction technique to separate the fats, which are subsequently evaporated and weighed.  This measurement of the total output of fecal fat per 24 hours in a three-day specimen is the most reliable test for steatorrhea.

This test requires a 72-hour stool collection.  The patient should abstain from alcohol during this time and maintain a high-fat diet (100gm/day) for three days before the test, and during the collection period.  The patient should call the laboratory for instructions on how to collect the specimen.

KEY

Strong or generally accepted link: is often a sign or symptom of
Strong or generally accepted link:
is often a sign or symptom of
Definite or direct link: is a sign or symptom of; increases risk of
Definite or direct link:
is a sign or symptom of; increases risk of
Very useful: is highly recommended for
Very useful:
is highly recommended for